DNA Oncogenic Virus-Induced Oxidative Stress, Genomic Damage, and Aberrant Epigenetic Alterations.
Mankgopo Magdeline KgatleCatherine Wendy SpearmanAsgar Ali KallaHenry Norman HairwadziPublished in: Oxidative medicine and cellular longevity (2017)
Approximately 20% of human cancers is attributable to DNA oncogenic viruses such as human papillomavirus (HPV), hepatitis B virus (HBV), and Epstein-Barr virus (EBV). Unrepaired DNA damage is the most common and overlapping feature of these DNA oncogenic viruses and a source of genomic instability and tumour development. Sustained DNA damage results from unceasing production of reactive oxygen species and activation of inflammasome cascades that trigger genomic changes and increased propensity of epigenetic alterations. Accumulation of epigenetic alterations may interfere with genome-wide cellular signalling machineries and promote malignant transformation leading to cancer development. Untangling and understanding the underlying mechanisms that promote these detrimental effects remain the major objectives for ongoing research and hope for effective virus-induced cancer therapy. Here, we review current literature with an emphasis on how DNA damage influences HPV, HVB, and EBV replication and epigenetic alterations that are associated with carcinogenesis.
Keyphrases
- dna damage
- epstein barr virus
- hepatitis b virus
- dna methylation
- oxidative stress
- genome wide
- diffuse large b cell lymphoma
- circulating tumor
- gene expression
- copy number
- dna repair
- cell free
- cancer therapy
- single molecule
- reactive oxygen species
- transcription factor
- liver failure
- endothelial cells
- high grade
- deep learning
- machine learning
- drug delivery
- high glucose
- papillary thyroid
- hydrogen peroxide
- squamous cell
- induced pluripotent stem cells
- stress induced